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1720 Abstracts December 2013carotid artery stenosis, and abdominal aortic aneurysm was 3.7%, 3.9%, and
0.9%, respectively. Prevalence of vascular disease increased with age (40-50
years: 2%, 51-60 years: 3.5%, 61-70 years: 7.1%, 71-80 years: 13.0%, 81-90
years: 22.3%, 91-100 years: 32.5%; P < .0001). The prevalence of vascular
disease in each vascular territory also increased with age. After adjustment
for sex, race-ethnicity, body mass index, family history of cardiovascular
disease, smoking, diabetes, hypertension, hypercholesterolemia, and exer-
cise, the odds of PAD (odds ratio [OR], 2.14; 95% conﬁdence interval
[CI], 2.12-2.15), carotid artery stenosis (OR, 1.8; 95% CI, 1.79-1.81),
and abdominal aortic aneurysm (OR, 2.33; 95% CI, 2.30-2.36) increased
with each decade of life.
Comment: Age is a well-known risk factor for atherosclerosis. The
data here, if anything, are likely to underestimate the prevalence of vascular
disease. Patients who present for screening studies, the so-called worried
well, may be more health oriented and live healthier lifestyles than those
who do not. After all, patients known to have vascular disease are not really
candidates for “screening” studies and, theoretically, would not be included
in the database. It seems they would be unlikely to pay for an examination to
conﬁrm what they already know.
Fistula First Is Not Always the Best Strategy for the Elderly
DeSilva RN, Patibandla BK, Vin Y, et al. J Am Soc Nephrol 2013;24:
1297-304.
Conclusions: Fistula ﬁrst is not clearly superior to graft ﬁrst in very
elderly patients. Each strategy is associated with similar mortality outcomes
in octogenarians and nonagenarians.
Summary: In patients requiring hemodialysis, one-third of ﬁstulas
fail to mature (Allon M et al, Kidney Int 2002;62:1109-24). In addition,
patients aged >65 years have twice the failure rate of younger patients
(Lok CE et al, J Am Soc Nephrol 2006;17:3204-12). A higher rate of
ﬁstulas that fail to mature may contribute to greater use of catheters.
Indeed, from the mid-1990s until recently, incident use of arteriovenous
(AV) grafts in elderly patients decreased from 28.2% to 4.2%, but at the
same time, incident catheter use increased from 56.8% to 82.3% (DeSilva
RN et al, Hemodial Int 2012;16:233-41; and Lacson E Jr et al, Am J
Kidney Dis 2009;54:912-21). Along with this, it is noted that the incident
hemodialysis population is aging, with an annual increase of 8% to 16% in
patients aged >75 years. In this paper, the authors sought to determine
mortality rates in the elderly population according to the initial type of
vascular access placed rather than the access used at initiation of hemodi-
alysis. The speciﬁc question was whether ﬁstula ﬁrst, as an intention-to-
treat strategy might not be the clearly superior predialysis vascular access
placement strategy in octogenarians. The paper analyzed data from
a cohort of 115,425 incident hemodialysis patients who were aged $65
years. Data were derived from the US Renal Data System with linked
Medicare claims. This allowed identiﬁcation of the ﬁrst predialysis vascular
access placed rather than just the ﬁrst access used for hemodialysis. All-
cause mortality outcomes based on the ﬁrst vascular access placed were
evaluated using proportional hazard models. The ﬁstula group was the
reference. In the study population, 21,436 patients had ﬁstulas as the ﬁrst
predialysis access placed, 3472 had grafts as the ﬁrst predialysis access, and
90,517 had catheters as the ﬁrst predialysis access. Patients with catheters
as their ﬁrst predialysis access demonstrated inferior survival compared
with patients with a ﬁstula (hazard ratio [HR], 1.77; 95% conﬁdence
interval [CI], 1.73-1.81; P < .001). There was no signiﬁcant difference
in mortality between patients with a graft as the ﬁrst access placed and
those with a ﬁstula as the initial access (HR, 1.05; 95% CI, 1.00-1.11;
P ¼ .06). Patients with grafts as their ﬁrst predialysis access had inferior
mortality outcomes compared with ﬁstulas for the group aged 67 to
#79 years (HR, 1.10; 95% CI, 1.02-1.17; P ¼ .007). However, differ-
ences between graft-ﬁrst and ﬁstula-ﬁrst groups were not statistically signif-
icant for the groups aged 80 to #89 years those aged >90 years. Overall,
only 50.7% of elderly patients with an AV ﬁstula placed ﬁrst used an AV
ﬁstula at the time of hemodialysis initiation. A higher percentage of those
patients within the AV ﬁstula-ﬁrst group used catheters at dialysis initiation
compared with the AV graft-ﬁrst group (43% vs 25%).
Comment: It is becoming increasingly evident that a ﬁstula-ﬁrst
strategy as a blanket strategy may not be appropriate for all patients
approaching hemodialysis. The authors’ data argue strongly for the fact
that perhaps what is more important is avoiding a catheter in the elderly
patient rather than whether hemodialysis is initiated with a ﬁstula or a graft.
The observational data here suggest placing an AV graft ﬁrst decreases the
chance of initiating hemodialysis with a catheter compared with a ﬁstula-ﬁrst
strategy. The clinical implication is that a ﬁstula-ﬁrst strategy should be used
in elderly patients who have a high chance for a successful ﬁstula but that the
remainder of patients should be considered for a graft to initiate
hemodialysis.Systematic Review and Meta-Analysis of Additional Technologies To
Enhance Angioplasty for Infrainguinal Peripheral Arterial Occlusive
Disease
Simpson EL, Michaels JA, Thomas SM, et al. Br J Surg 2013;100:
1128-37.
Conclusions: Among technologies available to enhance conventional
percutaneous transluminal balloon angioplasty (PTA), self-expanding stents,
drug-eluting stents, and drug-coated balloons appear to be the most prom-
ising technologies for future study.
Summary: There are a number of modiﬁcations of balloon angio-
plasty aimed at improving success of the initial recanalization and prevention
of late restenosis in the percutaneous treatment of infrainguinal peripheral
arterial occlusive disease. These technologies include stents, laser angio-
plasty, arthrectomy devices, drug-eluting stents, drug-coated balloons,
endovascular radiotherapy, and brachytherapy. This review is part of a larger
project looking at enhancements to angioplasty (Simpson EL et al, http://
www.hta.ac.uk/project/2324.asp). The purpose of the review was to eval-
uate the range of available additional technologies to enhance results of
infrainguinal PTA. The authors searched relevant electronic databases in
May 2011. The patient population studied was those with symptomatic
peripheral arterial occlusive disease undergoing endovascular treatment for
disease distal to the inguinal ligament. Interventions were additional tech-
niques compared with conventional PTA. Need for reintervention and
restenosis were the main outcome measures. Randomized clinical trials
were assessed for quality, and data were extracted to determine clinical effec-
tiveness. Where appropriate, meta-analysis was undertaken to produce risk
ratios (RRs). There were 40 randomized clinical trials selected. Meta-anal-
ysis showed a signiﬁcant beneﬁt at 6 months in reducing restenosis for
self-expanding stents (RR, 0.49) and drug-coated balloons (RR, 0.40)
and at 12 months for endovascular brachytherapy (RR, 0.63). Stent grafts
also signiﬁcantly reduced stenosis compared with PTA, as did drug-eluting
stents compared with bare-metal stents. The meta-analysis showed drug-
coated balloons were associated with lower reintervention rates than PTA
alone at 6 months (RR, 0.24) and at 24 months (RR, 0.27). Self-expanding
stents at 6 months also appeared to result in lower reintervention rates.
Other techniques did not show signiﬁcant treatment effects for restenosis
or reintervention.
Comment: It seems that every few months there is a new “wonder
technique” to reduce restenosis and reintervention in patients undergoing
percutaneous treatment of infrainguinal arteries. Although the conclusions
of this review must be tempered by small sample sizes and, frequently, by
lack of clinical outcome measures permitting direct comparison between
trials, it does appear not all adjuncts to balloon angioplasty are equal.
Because there are limited resources available for study of these adjuncts,
the value of this review is to identify those adjuncts most likely to have
beneﬁt when studied with respect to patient-oriented outcomes such as
measures of quality of life, reintervention, and symptomatic recurrence.
Myocardial Injury After Noncardiac Surgery and its Association With
Short-Term Mortality
van Waes JAR, Nathoe HM, de Graaff JC, et al; and the Cardiac Health
After Surgery (CHASE) Investigators. Circulation 2013;127:2264-71.
Conclusions: Postoperative myocardial injury is an independent
predictor of 30-day mortality after noncardiac surgery.
Summary: In high-risk surgical patients, isolated troponin elevations
are strong independent predictors of mortality within the ﬁrst year after
surgery (Levy M et al, Anesthesiology 2001;114:796-806). The VISION
study (Vascular Events in Noncardiac Surgery Patients Cohort Evaluation)
included >15,000 surgical patients and showed a strong association
between peak troponin levels postoperatively and 30-day mortality (Dever-
eaux PJ et al, JAMA 2012;307:2295-304). On the basis of the VISION
study, it has been suggested that routine postoperative troponin monitoring
could be implemented as standard of care in appropriate patients under-
going noncardiac surgery to provide better risk stratiﬁcation and long-
term patient management. The authors therefore sought to determine
the predictive value of postoperative troponin elevation with respect to
30-day mortality after noncardiac surgery. This was an observational
single-center cohort study of 2232 noncardiac surgical patients considered
intermediate-risk to high-risk. Patients were aged $60 years and underwent
surgery in 2011. Troponin was measured for the ﬁrst 3 postoperative days.
The association between postoperative myocardial injury (troponin I level
>0.06 mg/L) and all-cause 30-day mortality was determined using log
binomial regression analysis. Of the 1627 patients in whom troponin was
measured, 315 (19%) had myocardial injury as indicated by an elevated
troponin I level. All-cause death occurred in 56 patients (3%). The relative
risk of a minor increase in troponin (0.07-0.59 mg/L) was 2.4 (95% conﬁ-
dence interval, 1.3-4.2; P < .01). The relative risk of a 10- to 100-fold
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8.6; P < .01). The study included 255 vascular surgical patients, of whom
47 (18.4%) had moderate troponin elevations and 22 (8.6%) had troponin
elevations $0.60 mg/L; overall indicating 27% of vascular surgical patients
had a postoperative troponin elevation.
Comment: The authors obviously found a strong association between
postoperative myocardial injury as indicated by troponin elevations and
death in noncardiac surgery patients. They are not the ﬁrst to make this
observation but, importantly, point out that the magnitude of troponin
elevation postoperatively can be used to further stratify risk of postoperative
mortality. However, it remains to be determined whether there is a causal
relationship between troponin elevation and mortality and whether patients
with troponin elevations postoperatively would possibly beneﬁt from more
intensive postoperative cardiovascular treatment than those without
troponin elevations. One could argue virtually all atherosclerotic vascular
disease patients are at high cardiovascular risk.
Transfer of Patients With Suspected Acute Aortic Syndrome
Aggarwal B, Raymond C, Jacob J, et al. Am J Cardiol 2013;112:430-5.
Conclusions: Patients with acute aortic syndrome (aortic dissection)
can be safely transferred to specialized centers for deﬁnitive treatment.
Summary: Morbidity and mortality of patients with acute aortic
dissection remains high, especially within the ﬁrst 24 hours. Most patients
with acute aortic dissection present to a community hospital and will be
transferred to a specialized center. The authors performed an evaluation
of their aortic network to analyze performance in transport and care of
patients with acute aortic dissection during the transfer interval. From
March 2010 to June 2012, 263 consecutive patients with suspected acute
aortic dissection were transferred to a specialized unit: 47 transfers were
by ambulance, 196 by helicopter, and 20 by ﬁxed-wing jet. Transfers
went directly to a coronary care unit, bypassing the emergency department.
The transfer mortality rate was 0%, and the in-hospital mortality rate was 9%
(n ¼ 23). Initial systolic blood pressure and heart rate at the time of the
arrival of the transfer team to the referring hospital was compared with those
on arrival to the coronary care unit. Median transfer distance was 66 km
(interquartile range, 24-119 km). Median transfer time was 87 minutes
(interquartile range, 67-114 minutes). Signiﬁcant reductions in systolic
blood pressure were achieved by the transfer team, from 142 6 29 to
132 6 23 mm Hg (mean difference in systolic blood pressure, 10 mm
Hg; 95% conﬁdence interval, 7-14 mm Hg; P < .001). Heart rate was
also signiﬁcantly reduced, from 78 6 16 to 75 6 16 beats/min (mean
difference in heart rate, 3 beats/min; 95% conﬁdence interval, 1-4 beats/
min; P < .0001).
Comment: These data and those of Harris et al (Harris KM et al, Circ
Cardiovasc Qual Outcomes 2010;3:424-30) argue for the establishment of
aortic networks that can provide regionalization of care of patients with
complex aortic disease. The data show that it is possible to transfer patients
with acute aortic dissection safely and in fact improve their hemodynamic
status during the transport period. Establishment of aortic centers and
networks for complex acute pathology has the potential to improve the
care of thousands of patients with aortic disease.Endovascular vs Open Repair of Renal Artery Aneurysms: Outcomes of
Repair and Long-Term Renal Function
Tsilimparis N, Reeves JG, Dayama A, et al. J Am Coll Surg 2013;217:
263-9.
Conclusions: Endovascular repair of a renal artery aneurysm (RAA)
can be as safe and effective as open repair in selected patients with appro-
priate anatomy.
Summary: Many vascular surgeons consider a RAA >2 cm in diam-
eter appropriate for repair. There are, however, no solid recommendations
for the indication for RAA treatment or method of treatment. Small clinical
series and case reports have suggested the safety and efﬁcacy of endovascular
treatment of RAAs. In this study, the authors compared early outcomes,
reinterventions, and long-term renal function in patients with an RAA
treated with open repair or endovascular repair. This was a retrospective
review of patients with RAA treated between 2000 and 2012 at a single
institution. Comparisons were made for morbidity, mortality, freedom
from reintervention, and renal function between those treated with open
repair and endovascular repair. There were 44 RAA repairs in 40 patients
(28 women). The mean age was 54 6 13 years. Open repair was used in
20 RAAs (45%) and endovascular repair in 24 (55%). Mean aneurysm sizes
were 2.5 6 1.5 cm for open repair and 2.2 6 2.2 cm for endovascular repair
(P ¼ .66). Methods of endovascular repair included coil embolization, with
or without stent placement, in 19 patients (79%) and stent grafts in 4 (17%).
Open repair was excision or aneurysmorrhaphy of the aneurysm in 11
kidneys (55%), graft interposition or bypass in four (20%), and nephrecto-
mies in four (20%). One technical failure occurred in each group. Comor-
bidities were similar between the two groups. Endovascular repair and
open repair had equivalent perioperative morbidity (any complication:
open repair, 15%; endovascular repair, 17%; P ¼ 1.0). There was no
mortality in either group. Endovascular repair was associated with shorter
hospitalization (2 6 3.4 vs 6.3 6 2.5 days; P < .001). Mean follow-up
was similar, at 21 6 13 months for open repair and 27 6 36 months for
endovascular repair. A 30% reduction in the glomerular ﬁltration rate
occurred in 12.5% of the open repair patients and in 9.1% of the endovascu-
lar repair patients (P ¼ 1.00). Freedom from reintervention at 12 and 24
months was similar between the two groups, at 82% and 82% for open repair
vs 82% and 74% for endovascular repair (log-rank test ¼ 0.23).
Comment: The data suggests equal safety and morbidity for repair of
RAAs with open vs endovascular techniques. However, it is unlikely the
same spectrum of anatomy of RAA was treated in the two treatment
cohorts. In the open repair group, more aneurysms appeared to be near
the hilum of the kidney than in the endovascular repair group (50% vs
27%). The open repair group was also complicated by some patients who
were hemodynamically unstable while undergoing a repair of a ruptured
RAA and two additional patients who had attempted treatment of arterial
anatomy that may very well have precluded reconstruction. The authors
also had no information on split-renal function in the two treatment
cohorts. What the data really suggest is that it is possible, in selected cases,
to treat RAA with endovascular techniques. Concluding the two techniques
are equally safe and equally efﬁcacious given the limitations of patient selec-
tion, follow-up time, and follow-up methods is, however, probably not
appropriate.
